Evidence map›Paper›PMID 40486385›Full record

ArticleCureus2025

Early Implementation of the Navigator-Assisted Hypofractionation (NAVAH) Program in Hispanic-American Breast Cancer Patients.

Shearwood McClelland Iii, Abizairie Sanchez-Feliciano, Nelly Davila, Tamika K Smith, Ursula J Burnette, Louisa Onyewadume, Chesley W Cheatham

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shearwood McClelland IiiRadiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Abizairie Sanchez-FelicianoRadiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, USA.
Nelly DavilaRadiation Oncology, El Centro de Servicios Sociales, Lorain, USA.
Tamika K SmithRadiation Oncology, Case Western Reserve University School of Medicine, Cleveland, USA.
Ursula J BurnetteRadiation Oncology, Case Western Reserve University School of Medicine, Cleveland, USA.
Louisa OnyewadumeRadiation Oncology, Duke University Medical Center, Durham, USA.
Chesley W CheathamRadiation Oncology, Case Western Reserve University School of Medicine, Cleveland, USA.

Funding

Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
NCATS NIH HHS UM1 TR004528
6 · The paper itself

Abstract

Although cancer-related mortality in the United States (US) has generally been decreasing, this has not occurred among Hispanic populations, where cancer is the leading cause of death. The population growth of the Hispanic population in the US from 2010 to 2021 was substantially larger than the overall US population growth rate (24% vs. 7%). This increased population growth adds importance to addressing cancer care delivery barriers facing this patient population. We discuss early implementation of the Navigator-Assisted Hypofractionation (NAVAH) program in addressing these barriers.

Indexed as

breast cancerfinancial toxicityhispanic ethnicitypatient navigationradiation therapy

Identifiers

PMID40486385
PMCPMC12144923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.